home / stock / nmlsf / nmlsf news

NMLSF News and Press, Nova Mentis Life Science Corp From 11/02/21

Stock Information
Company Name: Nova Mentis Life Science Corp
Stock Symbol: NMLSF
Market: OTC
Website: novamentis.ca
Menu
NMLSF NMLSF Quote NMLSF Short NMLSF News NMLSF Articles NMLSF Message Board
Get NMLSF Alerts

News, Short Squeeze, Breakout and More Instantly...
NMLSF - U.S. FDA Approves Nova Mentis Orphan Drug Application

U.S. FDA Approves Nova Mentis Orphan Drug Application Canada NewsWire Psilocybin Fragile X Syndrome Treatment VANCOUVER, BC , Nov. 2, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"...
NMLSF - Nova Mentis Earns Psilocybin Orphan Drug Designation in Europe for Fragile X Syndrome

Nova Mentis Earns Psilocybin Orphan Drug Designation in Europe for Fragile X Syndrome PR Newswire VANCOUVER, BC , Oct. 26, 2021 /PRNewswire/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology...

NMLSF - Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation Fragile X Syndrome Treatment

Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation Fragile X Syndrome Treatment Canada NewsWire VANCOUVER, BC , Sept. 14, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF ) ("NOVA" or the "Company")...

NMLSF - Nova Mentis to Present at the H.C. Wainwright Global Investment Conference

Nova Mentis to Present at the H.C. Wainwright Global Investment Conference Canada NewsWire VANCOUVER, BC , Sept. 9, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and g...
NMLSF - Nova Mentis Expands Psilocybin Research Program Targets Obesity and Diabetes

Nova Mentis Expands Psilocybin Research Program Targets Obesity and Diabetes Canada NewsWire VANCOUVER, BC , Sept. 7, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and...

NMLSF - Nova Mentis Files Fragile X Orphan Drug Designation with European Medicines Agency

Nova Mentis Files Fragile X Orphan Drug Designation with European Medicines Agency Canada NewsWire VANCOUVER, BC , Aug. 12, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology compa...

NMLSF - Nova Mentis Files U.S. Patent Application for Psilocybin-Based Therapeutics

Nova Mentis Files U.S. Patent Application for Psilocybin-Based Therapeutics Canada NewsWire VANCOUVER, BC , July 29, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and ...
NMLSF - Nova Mentis Appoints Dr. Stephen Glazer as Director and Chief Science Officer

Nova Mentis Appoints Dr. Stephen Glazer as Director and Chief Science Officer Canada NewsWire VANCOUVER, BC , July 15, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology co...

NMLSF - Nova Mentis Autism Clinical Study Approved by Canadian Institutional Review Board

Nova Mentis Autism Clinical Study Approved by Canadian Institutional Review Board Canada NewsWire VANCOUVER, BC , June 23, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology compan...

NMLSF - Nova Mentis to Present at the H.C. Wainwright Psychedelics Conference

Nova Mentis to Present at the H.C. Wainwright Psychedelics Conference Canada NewsWire VANCOUVER, BC, June 10, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: LIBFF) ("NOVA" or the "Company"), a biotechnology company and global...
Previous 10 Next 10